Nicolì, V.; Tabano, S.M.; Colapietro, P.; Maestri, M.; Ricciardi, R.; Stoccoro, A.; Fontana, L.; Guida, M.; Miozzo, M.; Coppedè, F.;
et al. Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis. Genes 2022, 13, 696.
https://doi.org/10.3390/genes13040696
AMA Style
Nicolì V, Tabano SM, Colapietro P, Maestri M, Ricciardi R, Stoccoro A, Fontana L, Guida M, Miozzo M, Coppedè F,
et al. Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis. Genes. 2022; 13(4):696.
https://doi.org/10.3390/genes13040696
Chicago/Turabian Style
Nicolì, Vanessa, Silvia Maria Tabano, Patrizia Colapietro, Michelangelo Maestri, Roberta Ricciardi, Andrea Stoccoro, Laura Fontana, Melania Guida, Monica Miozzo, Fabio Coppedè,
and et al. 2022. "Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis" Genes 13, no. 4: 696.
https://doi.org/10.3390/genes13040696
APA Style
Nicolì, V., Tabano, S. M., Colapietro, P., Maestri, M., Ricciardi, R., Stoccoro, A., Fontana, L., Guida, M., Miozzo, M., Coppedè, F., & Migliore, L.
(2022). Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis. Genes, 13(4), 696.
https://doi.org/10.3390/genes13040696
